Roundtable Discussion – Why Psychiatry Needs Data Science (TIPS 2017)

This discussion was part of the 2017 Technology in Psychiatry Summit, sponsored by the McLean Institute for Technology in Psychiatry on November 6-7, 2017, at the JB Martin Conference Center, Harvard Medical School. Part of Connecting with Technology: Why Psychiatry (Still) Needs Data Science.

Advances in technology are creating almost limitless potential sources of data for understanding health and human behavior. This panel focuses on how we can take advantage of some of these data sources in the clinic and in the research laboratory using modern data analytic and machine learning approaches, to generate insights and improve clinical care.


Justin T. Baker, MD, PhD, is the scientific director of the McLean Institute for Technology in Psychiatry. He also serves as director of the Functional Neuroimaging and Bioinformatics for the Schizophrenia and Bipolar Disorder Research Program at McLean, assistant professor of psychiatry at Harvard Medical School, and associate director of the MGH Center for Law, Brain, and Behavior. His work aims to develop efficient strategies to monitor and intervene the course of mental illness..

Susan A. Murphy, PhD, joined Harvard University in 2017. Her research focuses on improving sequential, individualized, decision making in health, in particular on clinical trial design and data analysis, to inform the development of just-in-time adaptive interventions in mobile health. She is a fellow of the Institute of Mathematical Statistics, a fellow of the College on Problems in Drug Dependence, a former editor of the Annals of Statistics, a member of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine, and a 2013 MacArthur Fellow.

John Torous, MD, is a board-certified psychiatrist with a background in electrical engineering and computer science who researches digital mental health, specifically mobile mental health technology. He is the co-director of the digital psychiatry program at Beth Israel Deaconess Medical Center. He chairs the American Psychiatric Association’s smartphone app evaluation workgroup, is editor of the journal JMIR Mental Health, and an advisor to the Precision Medicine Initiative’s mood research efforts.


Carol Vallone is a 10-year member of the McLean Hospital board of trustees and currently chair of both the Strategy and Ventures committees. She is a seasoned education technology CEO who has launched, scaled, and sold multiple market-leading global companies that delivered online learning software and services for colleges and universities. Ms. Vallone is also a member of the board of trustees of Massachusetts General Hospital Institute of Health Professions.

Please visit to learn more about the McLean Institute for Technology in Psychiatry.